4th Microbiome Movement – Drug Development Summit Europe 2020
London, UK
Join us:
Biomica is delighted to participate at 4th Microbiome Movement – Drug Development Summit Europe 2020.
Dr. Elran Haber, Biomica’s Chief Executive Officer, will provide an overview of the Company’s work developing live bio-therapeutics using PRISM, a high-resolution microbiome analysis platform and a detailed functional genomic analysis; and participate in a panel discussion on current innovation & Future Integration of Microbiome-Based Approaches into Routine Oncology Practice.
Dr. Haber will be available to participate in one-on-one meetings.
More Details and Registration: https://microbiome-europe.com/